New POC allergy test has been cleared by FDA
The US medical agency FDA has granted Phadia the clearance to sell and market its new POC allergy test ImmunoCAP® Rapid product in US.
“This is a historical event in the diagnostic industry since it is the first semi-quantitative POC allergy test that has been FDA cleared. It is a major milestone for Phadia in building the ImmunoCAP franchise even stronger and will provide more patients with allergy-like symptoms the possibility to get a correct diagnosis” says Håkan Englund, Executive Vice President Phadia AB.
ImmunoCAP Rapid will be introduced on the US market later in the year. The European version of ImmunoCAP Rapid has been marketed and sold in selected European countries for over 2 years.
Most read news
Other news from the department research and development
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Philips and Concateno Announce Revolutionary Drugs-of-Abuse Testing System
ESA Expands European Customer Service
BEAM | FT-NIR-Prozessspektrometer | Bruker
PerkinElmer and IDBS Announce Software Collaboration to Improve High Content Screening Outcomes for Drug Discovery Research
LUM moves location of US subsidiary LUM Corp. to Austin, TX
The 2011 Körber Prize goes to Stefan Hell - With a groundbreaking idea the physicist has overcome the diffraction resolution barrier in optical microscopy
ECHA publishes an updated list of pre-registered substances
NIST research highlights promise of AFM-IR for quantitative nanoscale chemical analysis.
Fritsch as Authorized Economic Operator (AEO-F) certified